Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 FK 506 versus cyclosporine.

Literature DB >> 7679820

FK 506 versus cyclosporine.

T E Starzl¹.

Abstract

Entities: Chemical

Mesh：

Substances：
Cyclosporine
Tacrolimus

Year: 1993 PMID： 7679820 PMCID： PMC2954774

Source DB: PubMed Journal: Transplant Proc ISSN： 0041-1345 Impact factor: 1.066

× No keyword cloud information.

5 in total

1. Quality-of-life advantages of FK 506 vs conventional immunosuppressive drug therapy in cardiac transplantation.

Authors: M A Dew; R C Harris; R G Simmons; L H Roth; J M Armitage; B P Griffith
Journal: Transplant Proc Date: 1991-12 Impact factor: 1.066

Review 2. Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics.

Authors: T E Starzl; K Abu-Elmagd; A Tzakis; J J Fung; K A Porter; S Todo
Journal: Transplant Proc Date: 1991-02 Impact factor: 1.066

3. Hepatotrophic effects of FK506 in dogs.

Authors: T E Starzl; K A Porter; V Mazzaferro; S Todo; J Fung; A Francavilla
Journal: Transplantation Date: 1991-01 Impact factor: 4.939

4. The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver.

Authors: K Abu-Elmagd; J J Fung; M Alessiani; A Jain; R Venkataramanan; V S Warty; S Takaya; S Todo; W D Shannon; T E Starzl
Journal: Transplantation Date: 1991-07 Impact factor: 4.939

5. Intestinal transplantation in composite visceral grafts or alone.

Authors: S Todo; A G Tzakis; K Abu-Elmagd; J Reyes; K Nakamura; A Casavilla; R Selby; B M Nour; H Wright; J J Fung
Journal: Ann Surg Date: 1992-09 Impact factor: 12.969

5 in total

10 in total

1. A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients.

Authors: R Shapiro; M L Jordan; V P Scantlebury; C Vivas; J J Fung; J McCauley; P Randhawa; A J Demetris; W Irish; A Jain
Journal: Transplant Proc Date: 1995-02 Impact factor: 1.066

Review 2. Intestinal transplantation.

Authors: A G Tzakis; S Todo; T E Starzl
Journal: Annu Rev Med Date: 1994 Impact factor: 13.739

FK 506 versus cyclosporine.

1. Quality-of-life advantages of FK 506 vs conventional immunosuppressive drug therapy in cardiac transplantation.

Review 2. Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics.

3. Hepatotrophic effects of FK506 in dogs.

4. The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver.

5. Intestinal transplantation in composite visceral grafts or alone.

1. A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients.

Review 2. Intestinal transplantation.

3. Pediatric renal transplantation under tacrolimus-based immunosuppression.

4. Renal transplantation at the University of Pittsburgh: the impact of FK506.

5. Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patient benefits.

6. Tryptophan dynamics of the FK506 binding protein: time-resolved fluorescence and simulations.

Review 7. The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience.

8. A prospective randomized trial of FK506-based immunosuppression after renal transplantation.

9. Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet.

10. FK506 in pediatric kidney transplantation--primary and rescue experience.